Forte Biosciences Inc./$FBRX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Forte Biosciences Inc.
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
Ticker
$FBRX
Sector
Primary listing
Employees
22
Headquarters
Website
FBRX Metrics
BasicAdvanced
$457m
-
-$4.65
2.87
-
Price and volume
Market cap
$457m
Beta
2.87
52-week high
$35.80
52-week low
$9.10
Average daily volume
240k
Financial strength
Current ratio
2.753
Quick ratio
2.49
Profitability
EBITDA (TTM)
-76.902
Effective tax rate (TTM)
-1.89%
Management effectiveness
Return on assets (TTM)
-83.90%
Return on equity (TTM)
-188.40%
Valuation
Price to book
7.94
Price to tangible book (TTM)
7.94
Price to free cash flow (TTM)
-5.144
Free cash flow yield (TTM)
-19.44%
Free cash flow per share (TTM)
-3.637
Growth
Earnings per share change (TTM)
-43.62%
3-year earnings per share growth (CAGR)
-42.02%
FBRX News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs